Currently, there are 593.31M common shares owned by the public and among those 585.93M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of 1.12% and -4.22% over the past three months. LUV shares are trading -8.95% year to date (YTD), with the 12-month market performance down to -11.20% lower. It has a 12-month low price of $23.58 and touched a high of $36.12 over the same period. LUV has an average intraday trading volume of 7.88 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.63%, -3.93%, and 2.63% respectively.
Institutional ownership of Southwest Airlines Co (NYSE: LUV) shares accounts for 92.12% of the company’s 593.31M shares outstanding.
It has a market capitalization of $18.14B and a beta (3y monthly) value of 1.10. The stock’s trailing 12-month PE ratio is 43.09, while the earnings-per-share (ttm) stands at $0.71. The company has a PEG of 0.90 and a Quick Ratio of 0.85 with the debt-to-equity ratio at 0.78. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.51% over the week and 2.57% over the month.
Earnings per share for the fiscal year are expected to increase by 71.48%, and 46.55% over the next financial year. EPS should grow at an annualized rate of 48.12% over the next five years, compared to -29.29% over the past 5-year period.
Looking at the support for the LUV, a number of firms have released research notes about the stock. JP Morgan stated their Underweight rating for the stock in a research note on Mar-04-25, with the firm’s price target at $25. Argus coverage for the Southwest Airlines Co (LUV) stock in a research note released on February 11, 2025 offered a Buy rating with a price target of $35. BofA Securities was of a view on January 17, 2025 that the stock is Underperform, while Citigroup gave the stock Sell rating on January 16, 2025, issuing a price target of $31.50- $29.50. Morgan Stanley on their part issued Overweight rating on December 11, 2024.
